Naviter Wealth’s Eterna Therapeutics ERNA Stock Holding History

Naviter Wealth’s Portfolio ERNA Stock Details ERNA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q2	–	Sell	-126	Closed	-$8.24K	–	287
2025 Q1	$8.24K	Hold	126	–	–	﹤0.01%	273
2024 Q4	$13.9K	Sell	126 -84	-40%	-$22.8K	﹤0.01%	278
2024 Q3	$82.7K	Hold	210	–	–	0.01%	240
2024 Q2	$144K	Hold	210	–	–	0.02%	225
2024 Q1	$189K	Hold	210	–	–	0.03%	218
2023 Q4	$141K	Sell	210 -1	-0.5%	-$573	0.03%	210
2023 Q3	$173K	Sell	211 -3	-1%	-$2.76K	0.04%	200
2023 Q2	$182K	Buy	214 +2	+0.9%	+$2.02K	0.05%	219
2023 Q1	$271K	Hold	212	–	–	0.09%	169
2022 Q4	$387K	Buy	+212	New	+$299K	0.11%	166
2022 Q3	–	Sell	-210	Closed	-$814K	–	186
2022 Q2	$814K	Buy	210 +1	+0.5%	+$7.18K	0.33%	71
2022 Q1	$3.22M	Buy	209 +2	+1%	+$37.9K	1.07%	32
2021 Q4	$6.49M	Buy	+207	New	+$11.3M	1.94%	11

Other funds holding ERNA

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Corient Private Wealth Miami, Florida $69.9B AUM 22.19% 1-Year Est. Return

SCA

Sippican Capital Advisors Boston, Massachusetts $164M AUM 35.17% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

AssetMark Inc Concord, California $49B AUM 17.78% 1-Year Est. Return

EWA

EverSource Wealth Advisors Birmingham, Alabama $3.28B AUM 23.66% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

BNP Paribas Financial Markets Paris, France $206B AUM 31.61% 1-Year Est. Return

Naviter Wealth's ERNA Position: Q2 2025 in Review

Naviter Wealth sold out of Eterna Therapeutics (ERNA) in Q2 2025, closing a stake of 126 shares — an estimated $8.24K sold.

Naviter Wealth first reported a position in ERNA in Q4 2021 and held it in 13 quarters. The position peaked at $6.49M in Q4 2021. 9 funds tracked by Wall St. Rank hold ERNA as of Q2 2025.

Naviter Wealth reported no remaining Eterna Therapeutics position as of Q2 2025 after selling out during the quarter.
Naviter Wealth sold 126 Eterna Therapeutics shares in Q2 2025, an estimated $8.24K.
Naviter Wealth first reported a position in Eterna Therapeutics in Q4 2021 and held it in 13 quarters.
Naviter Wealth's Eterna Therapeutics position peaked at $6.49M in Q4 2021.
9 funds tracked by Wall St. Rank held Eterna Therapeutics as of Q2 2025.

Based on Naviter Wealth's 13F filing for Q2 2025, filed 28 Jul 2025.